Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > News & Media > Press Releases > Press Statements Archive > Press Release

Pfizer Press Statements Archive

July 24, 2013 - Pfizer Statement on PhRMA-EFPIA Principles for Responsible Clinical Trial Data Sharing
July 2, 2013 - Pfizer Mourns Loss of Prominent Leader and Respected Board Member
Pfizer Responds to New York Times Article on NIH Policy
Original Statement Provided to New York Times
March 15, 2013 - Pfizer Response To Global Consensus Statement On Menopausal Hormone Therapy
Zithromax (azithromycin) FDA Drug Safety Communication
November 29, 2012 - Pfizer Chairman and Chief Executive Officer Ian Read Issues Statement on White House Meeting
October 24, 2012 - Pfizer Donates Vials of Factor IX to the World Federation of Hemophilia to Help Developing Countries
October 3, 2012 - Findings from the Kronos Early Estrogen Prevention Study (KEEPS), presented today at The North American Menopause Society (NAMS) Annual Meeting in Orlando, Fla.
August 30, 2012 - The U.S. Food and Drug Administration issued a Drug Safety Communication on Revatio®
July 30, 2012 - Pfizer Helpful Answers mourns the loss of actor Lupe Ontiveros
July 9, 2012 - Ongoing Analyses have Helped Re-evaluate Benefit-Risk Profile of Hormone Therapy for Appropriate Menopausal Women
March 15, 2012 - Pfizer Response To Ongoing Evaluation Of Hormone Therapy And Breast Cancer, And What It Means For Menopausal Women Who Have Had A Hysterectomy
January 30, 2012 - Pfizer Joins Innovative Partnership to Eliminate or Control 10 Neglected Tropical Diseases by 2020
November 30, 2011 - Pfizer Statement Responding to Questions on Voluntary Lipitor Contracting Programs
November 17, 2011 - Pfizer applauds U.S. Sens. Pat Leahy (VT) and Charles Grassley (IA) and U.S. Reps. Patrick Meehan (PA) and Linda Sanchez (CA) for introducing the "Counterfeit Drug Penalty Enhancement Act of 2011."
November 16, 2011 - Pfizer announced that the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC)
November 2, 2011 - Pfizer Responds to Analysis in PLoS One, an Online Publication of the Public Library of Science
October 6, 2011 - Pfizer Statement Regarding Lyrica Epilepsty
September 8, 2011 - Pfizer Receives Complete Response Letter From FDA For Moderate-To-Severe Vasomotor Symptoms (VMS) Indication For Pristiq® (desvenlafaxine) Extended Release Tablets.
July 4, 2011 - Pfizer strongly believes in and supports Chantix as an important treatment option.
June 23, 2011 - Pfizer Inc. has received the European Commission Decision to renew the marketing authorization (MA) for Champix® (varenicline tartrate) for a further five year period for the treatment of smoking cessation in adults.
June 16, 2011 - Pfizer has studied Chantix (varenicline) in a randomized, double-blind, placebo-controlled clinical trial in smokers with certain types of cardiovascular disease.
June 8, 2011 - Pfizer Inc.ýs Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitro® (Roxarsone), a feed medicine used primarily in poultry production.
May 27, 2011 - Pfizer takes patient safety and regulatory reporting obligations very seriously. All post-marketing reports of adverse events are reviewed by Pfizer and reported to regulatory agencies, including FDA.
May 18, 2011 - Pfizer is appalled by the allegations of abuse in Libya. We condemn any misuse of our medicines. Pfizer stopped shipping all products to Libya in February, when sanctions were implemented by the international community. Our thoughts remain with the peopl
April 11, 2011 - New Guidelines Announce Lyrica® (pregabalin) Capsules CV — Pfizer is proud that Lyrica® (pregabalin) capsules CV, which is an FDA approved treatment indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN)
March 16, 2011 - Statement on Voluntary Recall of Embeda® Extended Release Capsules CII
December 20, 2010 - Pfizer has announced that it intends to recall one lot—approximately 19,000 bottles—of Lipitor 40 mg tablets (atorvastatin calcium) distributed in the U.S.
December 9, 2010 - Pfizer Inc. issued the following statement today in response to an article published in The Guardian regarding purported cables from the U.S. embassy in Nigeria that discuss Pfizer
November 24, 2010 - Guidelines to assist parties to the World Health Organization's Framework Convention on Tobacco Control (FCTC) were unanimously approved in Uruguay today by the fourth Conference of the Parties (COP4)
Pfizer is not involved in the film's production
Pfizer is not involved in the film's production
October 19, 2010 - "Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women"
Pfizer Statement on Conducting Clinical Trials in Response to the FDA Letter Dated April 9, 2010
June 9, 2010 - Pfizer Statement on Post Marketing Adverse Event Reporting in Response to the FDA Letter Dated May 26, 2010
Pfizer Statement on Conducting Clinical Trials in Response to the FDA Letter Dated April 9, 2010
February 9, 2009 - Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators
January 30, 2009 - Pfizer Responds to Divided Ruling by U.S. Court of Appeals for 2nd Circuit in Cases Related to Trovan Study in Nigeria
January 22, 2009 - Pfizer Inc today issued the following statement on the proposed Physician Sunshine Act
August 13, 2008 - Letter from Jeff Kindler Chairman and CEO, Pfizer Inc, to The Honorable Max Baucus, Chairman, Finance Committee, United States Senate
July 15, 2008 - Testimony of Jeff Kindler Chairman and CEO, Pfizer Inc, before the Senate Finance Committee on International Enforcement of Intellectual Property Rights and American Competitiveness
May 29, 2008 - A message about Chantix® (varenicline) from Pfizer
May 8, 2008 - Testimony before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations
Pfizer Response To Initial, Non-Final Office Action by US Patent And Trademark Office
July 31, 2007 - Pfizer Files Challenge to Improper Nigerian Government Report in Trovan Cases
May 29, 2007 - Pfizer Statement on Trovan
Safe Antibiotic Use in Food Producing Animals
Trovan Litigation, Statement of Defense
Trovan Statement of Defense Summary
Trovan Fact Sheet

Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

pdf

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.
Printable Version
 
 

Current Stock Price

. .
.
%Change . 52 Wk. High .
Day High . 52 Wk. Low .
Day Low . Mkt. Cap(Bil) .
Open .    
Prev Close . Symbol .
Vol. . Exchange .

Online Pfizer Press Kit

Our press kit provides information that might help you write stories or simply find out more about Pfizer.

 

Source URL: http://www.pfizer.com/news/press-release/press-statement-archive